ProPhase Labs is a biotech, genomics, and diagnostics company that offers Whole Genome Sequencing, develops groundbreaking compounds and products, and licenses and commercializes products. The company also provides OTC manufacturing services and consumer healthcare product development.

Nebula Genomics

ProPhase Diagnostics

ProPhase Labs, Inc. is a growth oriented and diversified diagnostics, genomics and biotech company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research. The Company continues to provide traditional CLIA molecular laboratory services, including COVID-19 testing. The Company also continues to operate a state-of-the-art contract manufacturing subsidiary and the TK Supplements line of dietary supplements, distributed in food, drug and mass stores throughout the country.

Dutchess Opportunity Fund

ProPhase Labs

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

COM:PROPHASELABS

ProPhase Labs

Last Close

0.78

22/11 21:00

Market Cap

66.20M

Beta: -

Volume Today

199.40K

Avg: -

Analysis Not Available